Success Metrics

Clinical Success Rate
66.7%

Based on 2 completed trials

Completion Rate
67%(2/3)
Active Trials
2(29%)
Results Posted
0%(0 trials)
Terminated
1(14%)

Phase Distribution

Ph phase_1
4
57%
Ph not_applicable
1
14%
Ph phase_2
2
29%

Phase Distribution

4

Early Stage

2

Mid Stage

0

Late Stage

Phase Distribution7 total trials
Phase 1Safety & dosage
4(57.1%)
Phase 2Efficacy & side effects
2(28.6%)
N/ANon-phased studies
1(14.3%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

2

trials recruiting

Total Trials

7

all time

Status Distribution
Active(2)
Completed(2)
Terminated(1)
Other(2)

Detailed Status

Recruiting2
unknown2
Completed2
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
2
Success Rate
66.7%
Most Advanced
Phase 2

Trials by Phase

Phase 14 (57.1%)
Phase 22 (28.6%)
N/A1 (14.3%)

Trials by Status

recruiting229%
terminated114%
unknown229%
completed229%

Recent Activity

Clinical Trials (7)

Drug Details

Intervention Type
DRUG
Total Trials
7